Drug-class-specific changes in the volume and cost of antidiabetic medications in Poland between 2012 and 2015

• Andrzej Śliwczyński,

  Affiliations Division of Quality Services, Procedures and Medical Standards, Medical University in Lodz, Lodz, Poland, National Health Fund, Warsaw, Poland

  ⨯
• Melania Brzozowska,

  Affiliations Division of Quality Services, Procedures and Medical Standards, Medical University in Lodz, Lodz, Poland, National Health Fund, Warsaw, Poland

  ⨯
• Andrzej Jacyna,

  Affiliation National Health Fund, Warsaw, Poland

  ⨯
• Petre Iltchev,

  Affiliation Health Care Policy Department, Medical University of Lodz, Lodz, Poland

  ⨯
• Tymoteusz Iwańczuk,

  Affiliation The Agency for Health Technology Assessment and Tariff System, Warsaw, Poland

  ⨯
• Waldemar Wierzba,

  Affiliation University of Humanities and Economics, Lodz, Poland

  ⨯
• Michał Marczak,

  Affiliation Division of Quality Services, Procedures and Medical Standards, Medical University in Lodz, Lodz, Poland

  ⨯
• Katarzyna Orlewska,

  Affiliation Medical University of Warsaw, Warsaw, Poland

  ⨯
• Piotr Szymański,

  Affiliation Institute of Cardiology, Warsaw, Poland

  ⨯
• Ewa Orlewska

  * E-mail: eorl@ujk.edu.pl

  Affiliation Jan Kochanowski University in Kielce, Kielce, Poland

  http://orcid.org/0000-0001-5731-4316

  ⨯